9.59
[]. Amy Meng, et al. Exposure-response relationships for the efficacy and safety of filgotinib and its metabolite GS-829845 in subjects with rheumatoid arthritis based on phase 2 and phase studies. Br J Clin Pharmacol. 2022 Jul;88():2-22.
[2]. Chia-Hsiang Hsueh, et al. Evaluation of the potential drug interactions mediated through P-gp, OCT2, and MATE/2K with filgotinib in healthy subjects. Clin Transl Sci. 2022 Feb;5(2):6-0.
H02-H5-H9-H5
P26-P264-P20-P2-P280-P02+P52-P04+P40-P0-P62+P64-P405-P50
GHS0
![]()
![]()